OpenSight Augmented Reality System for Microsoft HoloLens Cleared by FDA
By HospiMedica International staff writers Posted on 12 Nov 2018 |
Image: The OpenSight Augmented Reality System (Photo courtesy of Novarad).
The FDA has granted 510(k) clearance to the OpenSight Augmented Reality System, making it the first AR medical solution for Microsoft HoloLens to be cleared for use in pre-operative surgical planning. Developed by Novarad (American Fork, UT, USA), a provider of specialized enterprise imaging and workflow solutions, OpenSight renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body.
OpenSight utilizes the Microsoft HoloLens headset that not only allows doctors to see the 3D patient images in AR, but also to see the patient (reality) at the same time, allowing them to more accurately plan surgery. OpenSight AR provides a better understanding of anatomic relationships because the images are co-localized to the patient. Pre-operative planning with OpenSight makes it possible to highlight relevant anatomy and critical structures to avoid, as well as position virtual tools and guidance systems to more accurately plan a surgical approach.
“This is transformative technology that will unite preoperative imaging with augmented reality to improve the precision, speed and safety of medical procedures,” said Dr. Wendell Gibby, Novarad CEO and co-creator of OpenSight. “This internal visualization can now be achieved without the surgeon ever making an incision, improving outcomes in a world of more precise medicine.”
OpenSight utilizes the Microsoft HoloLens headset that not only allows doctors to see the 3D patient images in AR, but also to see the patient (reality) at the same time, allowing them to more accurately plan surgery. OpenSight AR provides a better understanding of anatomic relationships because the images are co-localized to the patient. Pre-operative planning with OpenSight makes it possible to highlight relevant anatomy and critical structures to avoid, as well as position virtual tools and guidance systems to more accurately plan a surgical approach.
“This is transformative technology that will unite preoperative imaging with augmented reality to improve the precision, speed and safety of medical procedures,” said Dr. Wendell Gibby, Novarad CEO and co-creator of OpenSight. “This internal visualization can now be achieved without the surgeon ever making an incision, improving outcomes in a world of more precise medicine.”
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures